Orchid Pharma Limited
Stock Forecast, Prediction & Price Target

Orchid Pharma Limited Financial Estimates

Orchid Pharma Limited Revenue Estimates

Orchid Pharma Limited EBITDA Estimates

Orchid Pharma Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2021 3/31/2022 3/31/2024 3/31/2026 3/31/2027
Revenue
 
% change YoY
₹4.50B
 
N/A
₹5.59B
 
24.32%
₹8.19B
 
46.43%
Avg: ₹14.84B
Low: ₹14.84B
High: ₹14.84B
avg. 81.13%
Avg: ₹22.52B
Low: ₹22.52B
High: ₹22.52B
avg. 51.77%
Net Income
 
% change YoY
₹-1.16B
 
N/A
₹-19.51M
 
98.32%
₹921.66M
 
4823.58%
Avg: ₹2.17B
Low: ₹1.58B
High: ₹2.45B
avg. 135.62%
Avg: ₹4.67B
Low: ₹4.67B
High: ₹4.67B
avg. 115.36%
EBITDA
 
% change YoY
₹658.73M
 
N/A
₹616.24M
 
-6.45%
₹1.41B
 
130.29%
Avg: ₹1.59B
Low: ₹1.59B
High: ₹1.59B
avg. 12.51%
Avg: ₹2.42B
Low: ₹2.42B
High: ₹2.42B
avg. 51.77%
EPS
 
% change YoY
-$28.55
 
N/A
-$0.48
 
98.31%
$19.06
 
4070.83%
Avg: $41.23
Low: $31.2
High: $48.4
avg. 116.33%
Avg: $92.2
Low: $92.2
High: $92.2
avg. 123.60%
Operating Expenses
 
% change YoY
₹2.59B
 
N/A
₹2.65B
 
2.28%
₹800.77M
 
-69.86%
Avg: ₹1.19B
Low: ₹1.19B
High: ₹1.19B
avg. 49.37%
Avg: ₹1.81B
Low: ₹1.81B
High: ₹1.81B
avg. 51.77%

FAQ

What is Orchid Pharma Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 125.49% in 2026-2027.

We have gathered data from 3 analysts. Their low estimate is 1.58B, average is 2.17B and high is 2.45B.

What is Orchid Pharma Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 66.45% in 2026-2027.

We have gathered data from 3 analysts. Their low revenue estimate is ₹14.84B, average is ₹14.84B and high is ₹14.84B.

What is Orchid Pharma Limited stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 119.96% in 2026-2027.

We have gathered data from 3 analysts. Their low earnings per share estimate is $31.2, average is $41.23 and high is ₹48.4.